SCHEMBL23291389

SCHEMBL23291389

CCCCOC(=O)NCCc1ccc(NC2CCS(O)(O)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.44
KMT2A Q03164 1/20 0.44
ACHE P22303 10/20 0.42
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
GAA P10253 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23928128 0.81 NAMPT (0.51) MAPK1HTT
SCHEMBL23928177 0.79 NPC1 (0.42) KMT2ASMN1; SMN2TSHRCNR1
SCHEMBL21382248 0.75 KMT2A (0.57) GLAKMT2AACHEHDAC3HDAC4
SCHEMBL4769744 0.75 KMT2A (0.57) GLAKMT2AACHEMAPK1SMN1; SMN2
SCHEMBL8585756 0.74 KMT2A (0.56) GLAKMT2AACHEHDAC3HDAC4
SCHEMBL5110887 0.74 NPC1 (0.63) GLAKMT2AACHEGAASMN1; SMN2
SCHEMBL27887140 0.73 KMT2A (0.55) GLAKMT2AACHESMN1; SMN2HDAC3
SCHEMBL7201386 0.73 CNR2 (0.58) GLAKMT2AACHEADRB3
SCHEMBL23928131 0.73 NAMPT (0.51) KMT2AMAPK1HTT
SCHEMBL28364907 0.72 CA1 (0.54) GLAKMT2AACHEHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3814356-A1 TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS Zhejiang Vimgreen Pharmaceuticals, Ltd (CN) 2021-05-05 EP disclosed